Absci (ABSI) Accumulated Expenses (2020 - 2025)
Absci's (ABSI) quarterly Accumulated Expenses came in at $8.2 million in Q3 2025, down 54.9% year-on-year from $18.2 million in Q3 2024, and up 43.99% quarter-over-quarter from $5.7 million in Q2 2025.
Absci (ABSI) Accumulated Expenses (2020 - 2025) Analysis & Trends
Absci has disclosed Accumulated Expenses across 6 years of filings, most recently posting $8.2 million for Q3 2025.
- Accumulated Expenses for Q3 2025 came in at $8.2 million, down 54.9% year-over-year; the trailing twelve-month figure through Sep 2025 was $8.2 million (down 54.9% YoY), and the FY2024 annual result was $6.8 million, up 4.41% from the prior year.
- Accumulated Expenses came in at $8.2 million for Q3 2025 at Absci, up from $5.7 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $25.6 million in Q1 2022 to a low of $4.3 million in Q1 2025.
- The 5-year median for Accumulated Expenses is $16.8 million (2023), against an average of $14.9 million.
- Across the five-year window, Accumulated Expenses surged 1011.15% in 2021 and slumped 72.36% in 2025, its largest moves.
- Absci's Accumulated Expenses stood at $17.4 million in 2021, then increased by 17.48% to $20.5 million in 2022, then tumbled by 68.0% to $6.6 million in 2023, then climbed by 4.41% to $6.8 million in 2024, then advanced by 20.27% to $8.2 million in 2025.
- The last three Accumulated Expenses figures came in at $8.2 million (Q3 2025), $5.7 million (Q2 2025), and $4.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8.23 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 6.84 Mn |
| Sep 30, 2024 | 18.25 Mn |
| Jun 30, 2024 | 16.85 Mn |
| Mar 31, 2024 | 15.40 Mn |
| Dec 31, 2023 | 6.55 Mn |
| Sep 30, 2023 | 19.68 Mn |
| Jun 30, 2023 | 16.71 Mn |
| Mar 31, 2023 | 18.09 Mn |
| Dec 31, 2022 | 20.48 Mn |
| Sep 30, 2022 | 20.98 Mn |
| Jun 30, 2022 | 17.05 Mn |
| Mar 31, 2022 | 25.64 Mn |
| Dec 31, 2021 | 17.43 Mn |
| Sep 30, 2021 | 15.28 Mn |
| Jun 30, 2021 | 14.00 Mn |
| Dec 31, 2020 | 1.57 Mn |